Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vortioxetine: First Global Approval
Andrew Gibb, Emma D. Deeks
Drugs (2013) Vol. 74, Iss. 1, pp. 135-145
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Todd M. Hillhouse, Joseph H. Porter
Experimental and Clinical Psychopharmacology (2015) Vol. 23, Iss. 1, pp. 1-21
Open Access | Times Cited: 526
Serotonin: A never-ending story
Berend Olivier
European Journal of Pharmacology (2014) Vol. 753, pp. 2-18
Open Access | Times Cited: 230
Emerging drugs for the treatment of anxiety
James W. Murrough, Sahab Yaqubi, Sehrish Sayed, et al.
Expert Opinion on Emerging Drugs (2015) Vol. 20, Iss. 3, pp. 393-406
Open Access | Times Cited: 153
Clinically relevant interactions between newer antidepressants and second-generation antipsychotics
Edoardo Spina, José de León
Expert Opinion on Drug Metabolism & Toxicology (2014) Vol. 10, Iss. 5, pp. 721-746
Open Access | Times Cited: 105
The molecular pathophysiology of depression and the new therapeutics
Haihua Tian, Zhenyu Hu, Jia Xu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 65
Post-marketing safety evaluation of Vortioxetine: A decade-long pharmacovigilance study based on the FAERS database
Jianhong Wu, Na Li, Jun Gu, et al.
Journal of Affective Disorders (2025)
Closed Access | Times Cited: 1
Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder
Chi‐Un Pae, Sheng‐Min Wang, Hans‐Jürgen Möller, et al.
Journal of Psychiatry and Neuroscience (2015) Vol. 40, Iss. 3, pp. 174-186
Open Access | Times Cited: 64
Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure‐Activity Relationships
Ravi Kumar, Bhaskar Sahu, Shelly Pathania, et al.
ChemMedChem (2021) Vol. 16, Iss. 12, pp. 1878-1901
Closed Access | Times Cited: 47
Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant
Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Paulina Misztak, et al.
Pharmacological Reports (2017) Vol. 69, Iss. 4, pp. 595-601
Closed Access | Times Cited: 61
The Black Book of Psychotropic Dosing and Monitoring.
Charles DeBattista, Alan F. Schatzberg
PubMed (2024) Vol. 54, Iss. 3, pp. 8-59
Closed Access | Times Cited: 5
Post-marketing safety surveillance of vortioxetine hydrobromide: a pharmacovigilance study leveraging FAERS database
Ying Zhang, Shengzhu Sun, Yaogui Ning
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?
Horrick Sharma, Soumava Santra, Aloke K. Dutta
Future Medicinal Chemistry (2015) Vol. 7, Iss. 17, pp. 2385-2406
Open Access | Times Cited: 42
The effectiveness of vortioxetine on neurobiochemical metabolites and cognitive of major depressive disorders patients: A 8-week follow-up study
Yiliang Zhang, Shunkai Lai, Jianzhao Zhang, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 799-807
Closed Access | Times Cited: 4
Carbon-Based Nanomaterials 4.0
Ana M. Díez‐Pascual
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3032-3032
Open Access | Times Cited: 4
A Sensitive Precolumn Derivatization Method for Determination of Piperazine in Vortioxetine Hydrobromide Using a C8 Column and High-Performance Liquid Chromatography–Mass Spectrometry
Shubo Dong, Zhengyu Yan, Hanyue Yang
Analytical Sciences (2016) Vol. 32, Iss. 12, pp. 1333-1338
Open Access | Times Cited: 21
New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine
Laura Orsolini, Carmine Tomasetti, Alessandro Valchera, et al.
Expert Review of Neurotherapeutics (2016) Vol. 16, Iss. 5, pp. 483-495
Closed Access | Times Cited: 20
Results of a real-world study on vortioxetine in patients with major depressive disorder in South East Asia (REVIDA)
Cheuk Ngen Chin, Azhar Md. Zain, Solaphat Hemrungrojn, et al.
Current Medical Research and Opinion (2018) Vol. 34, Iss. 11, pp. 1975-1984
Closed Access | Times Cited: 20
Simultaneous quantification of vortioxetine, carvedilol and its active metabolite 4-hydroxyphenyl carvedilol in rat plasma by UPLC–MS/MS: Application to their pharmacokinetic interaction study
Yi Huang, Shuang-li Zheng, Yong-yang Pan, et al.
Journal of Pharmaceutical and Biomedical Analysis (2016) Vol. 128, pp. 184-190
Closed Access | Times Cited: 18
A quantitative LC-MS/MS method for simultaneous determination of deuvortioxetine, vortioxetine and their carboxylic acid metabolite in rat plasma, and its application to a toxicokinetic study
Mei Qin, Hongqun Qiao, Yanjuan Yuan, et al.
Analytical Methods (2018) Vol. 10, Iss. 9, pp. 1023-1031
Closed Access | Times Cited: 18
Vortioxetine Disposition in Obesity
David J. Greenblatt, Jerold S. Harmatz, Christina R. Chow
Journal of Clinical Psychopharmacology (2018) Vol. 38, Iss. 3, pp. 172-179
Closed Access | Times Cited: 17
A double‐blind, placebo‐controlled study of vortioxetine in the treatment of binge‐eating disorder
Jon E. Grant, Stephanie Valle, Elizabeth Cavic, et al.
International Journal of Eating Disorders (2019) Vol. 52, Iss. 7, pp. 786-794
Open Access | Times Cited: 17
Antidepressants and Sexual Dysfunctions: a Translational Perspective
Berend Olivier, Berend Olivier
Current Sexual Health Reports (2019) Vol. 11, Iss. 3, pp. 156-166
Open Access | Times Cited: 17
Structures and physicochemical properties of vortioxetine salts
Xinbo Zhou, Xiu-Rong Hu, Su-Xiang Wu, et al.
Acta Crystallographica Section B Structural Science Crystal Engineering and Materials (2016) Vol. 72, Iss. 5, pp. 723-732
Closed Access | Times Cited: 14
To Market, To Market—2013
Joanne J. Bronson, Amelia Black, T. G. Murali Dhar, et al.
Annual reports in medicinal chemistry (2014), pp. 437-508
Closed Access | Times Cited: 12
Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates
Michał Antoszczak, Anna Markowska, Janina Markowska, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 11, pp. 2137-2174
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top